Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary
albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated …

Chronic kidney disease is a common disorder and its prevalence is increasing worldwide.
Early diagnosis on the basis of presence of proteinuria or reduced estimated glomerular …

Background: Sodium–glucose cotransporter-2 (SGLT2) inhibitors have the potential to alter
the natural history of chronic kidney disease (CKD), and they should be included in cost …

Background Chronic kidney disease (CKD) is a major health problem with an increasing
incidence worldwide. Data on the cost-effectiveness of CKD screening in the general …

Context Hyperhomocysteinemia is frequently observed in patients with diabetic
nephropathy. B-vitamin therapy (folic acid, vitamin B 6, and vitamin B 12) has been shown to …

BACKGROUND: Microalbuminuria screening may detect chronic kidney disease in its early
stages, allowing for treatment that delays or prevents disease progression. The cost …

Background and Purpose—Microalbuminuria, a marker of both kidney disease and
endothelial dysfunction, may be associated with global vascular risk, but the nature and …

Osteodistrofia renal ha sido un término empleado tradicionalmente para referirse a las
alteraciones del metabolismo óseo-mineral de los pacientes con enfermedad renal crónica …

Objectives: Chronic kidney disease is, increasingly, both a contributor to premature deaths
and a financial burden to the health system, and is estimated to affect between 10% and …

Context Hypertension affects one third of the US adult population. Although cost-
effectiveness analyses of antihypertensive medicines have been published, a …